Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent

Journal of Pharmaceutical and Biomedical Analysis

Volumn 95, Issue , 2014, Pages 61-67

  Saracino, Maria Addolorata ^a   Mercolini, Laura ^a   Carbini, Giorgia ^a   Volterra, Vittorio ^a   Quarta, Antonio Lucio ^b   Amore, Mario ^c   Raggi, Maria Augusta ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Mental Health Local Health Unit ASL CSM Parma Nord SPOI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Agomelatine; Dried blood spots; Liquid chromatography fluorescence detector; Plasma; Saliva

Indexed keywords

AGOMELATINE; AMISULPRIDE; CLONAZEPAM; DELORAZEPAM; ESCITALOPRAM; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; VENLAFAXINE; ACETAMIDE DERIVATIVE; ANTIDEPRESSANT AGENT; MELATONIN;

ACCURACY; ADULT; ARTICLE; BLOOD SAMPLING; DRIED BLOOD SPOT TESTING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG SALIVA LEVEL; FEMALE; FLUORESCENCE ANALYSIS; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MICROWAVE RADIATION; PLASMA; PRIORITY JOURNAL; SALIVA; AGONISTS; CHEMISTRY; DRUG STABILITY; MIDDLE AGED; PROCEDURES; SOLID PHASE MICROEXTRACTION;

ACETAMIDES; ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FEMALE; FLUOROMETRY; HUMANS; MALE; MELATONIN; MIDDLE AGED; SOLID PHASE MICROEXTRACTION;

EID: 84896098934     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.02.005     Document Type: Article

References (16)

1. World Health Organization, Depression. (accessed September, 2013). http://www.who.int/mental_health/management/depression/definition/en/.
2. PharmaLive Special Reports, Top 500 prescription drugs. (accessed September, 2013). http://www.pharmalive.com/special_reports/sample.cfm%3FreportID=191.
3. Papakostas G.I., Fava M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialog. Clin. Neurosci. 2008, 10:439-451.
4. Racagni G., Popoli M. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialog. Clin. Neurosci. 2008, 10:385-400.
5. de Bodinat C., Guardiola-Lemaitre B., Mocaër E., Renard P., Muñoz C., Millan M.J. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat. Rev. Drug Discov. 2010, 8:628-642.
6. Srinivasan V., Pandi-Perumal S.R., Trakht I., Spence D.W., Hardeland R., Poeggeler B., Cardinali D.P. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Psychiatry Res. 2009, 165:201-214.
7. Millan M.J., Marin P., Kamal M., Jockers R., Chanrion B., Labasque M., Bockaert J., Mannoury la Cour C. The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptors. Int. J. Neuropsychopharmacol. 2011, 14:768-783.
8. Fornaro M., Prestia D., Colicchio S., Perugi G. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation. Curr. Neuropharmacol. 2010, 8:287-304.
9. Voican C.S., Corruble E., Naveau S., Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am. J. Psychiatry. 2013, 10.1176/appi.ajp.2013.13050709.
10. European Medicines Agency CHMP Assessment for Valdoxan, London 2008, Doc. Ref.: EMEA/655251/2008.
11. Mandrioli R., Mercolini L., Saracino M.A., Raggi M.A. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Curr. Med. Chem. 2012, 19:1846-1863.
12. Patil S.R., Nerurkar K.K., Kalamkar A.M., Pukale V., Mangaonkar K.V., Pingale S.G. Validated LC-MS/MS method for quantification of agomelatine in human plasma and its application in a pharmacokinetic study. J. Mass Spectrom. 2012, 47:23-28.
13. Wang X., Zhang D., Liu M., Zhao H., Du A., Meng L., Liu H. LC-MS/MS method for the determination of agomelatine in human plasma and its application to a pharmacokinetic study. Biomed. Chromatogr. 2014, 28:218-222.
14. United States Pharmacopeia United States Pharmacopeial Convention, Rockville, MD 2009, 734-736. 32th ed.
15. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 2000, 17:1551-1557.
16. Abdel-Rehim M. Recent advances in microextraction by packed sorbent for bioanalysis. J. Chromatogr. A 2010, 1217:2569-2580.